期刊
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
卷 132, 期 3, 页码 938-+出版社
AMER CHEMICAL SOC
DOI: 10.1021/ja907886v
关键词
-
资金
- University of Washington
attractive strategy for circumventing tills problem is to engineer a protein of interest to be sensitive to a pharmacological agent of choice. Here, we report a chemical genetic method for regulating the catalytic activity of signaling enzymes with a small molecule. This approach uses the interaction of the antiapoptotic protein Bcl-xL and a BH3 peptide as an autoinhibitory switch that call be controlled with a small molecule. We applied this Strategy to the (guanine nucleotide exchange factor Intersectin, which is a selective activator of the GTPase Cdc42. Replacing Intersectin's regulatory domains with the BH3 peptide/Bcl-xL binding module generated a panel of synthetic GEF constructs that call be activated with a competitive ligand. Importantly, the nucleotide exchange activities of these synthetic Intersectin constructs call be controlled ill a rapid and dose-dependent manner. The modular nature of this strategy should make it useful for engineering other enzymes involved ill signal transduction.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据